AestheticsFeatured ArticlesNew Articles

Oral Collagen Supplementation: A Systematic Review of Dermatological Applications

By September 14, 2020October 27th, 2020No Comments

Featured Article

Featured Article

800 patients who took up to 10 grams of collagen per day, experienced improvement in skin elasticity, moisture retention, and increased density of collagen fibers in the skin.

Read more

Improvements in skin health is a well-researched benefit of taking collagen – in fact, according to a January 2019 Journal of Drugs in Dermatology study, (recently featured in an Every Day Health article, ” 8 Potential Benefits of Collagen – and 1 Thing it Can’t Do”), 800 patients who took up to 10 grams of collagen per day, experienced improvement in skin elasticity, moisture retention, and increased density of collagen fibers in the skin.

Franchesca D. Choi BS RPh, Calvin T. Sung BS, Margit L.W. Juhasz MD, Natasha Atanaskova Mesinkovska MD PhD

Nutrition is thought to play an important role in skin homeostasis. The use of nutraceuticals or “functional foods” in skincare along with technological innovations within the food industry has been rising.

In 2016, the collagen market was valued at an estimated 3.71 billion USD and is projected to reach 6.63 billion USD by 2025. Collagen supplements, originating from various sources (eg, porcine, bovine, marine) and available in numerous formulations (eg, protein, gelatin, hydrolysate, peptides), are marketed as improving skin integrity and modulating skin aging.

However, even with this increase in patient interest and market share, the use of collagen supplementation in dermatology remains controversial due to the lack of regulation on quality and quantity of ingredients in over-the-counter collagen supplements, as well as minimal peer-reviewed literature on the subject. Fortunately, there are increasing numbers of clinical studies regarding potential effects of collagen-based dietary supplements on skin.

Read Full Article Now
Article Cited in this Post

You May Also Like

Journal of Drugs in Dermatology JDD Article Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey

Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey

| Featured Articles, Latest News, Skin Cancer, The Latest | No Comments
Neoadjuvant Hedgehog Inhibitors: Gaining Ground in Mohs for BCC? A recent survey of American College of Mohs Surgery members reveals that 22% of Mohs surgeons are already using hedgehog pathway…

JDD in the News: Proposed Universal Classification System for Topical Corticosteroids 

| Featured Articles, JDD Highlights, JDD in the Media, Skincare, The Latest | No Comments
Healio profiled a new universal classification system for topical corticosteroids that could reduce confusion across countries. The system was published in the May Journal of Drugs in Dermatology in an…

A Scientific Approach to Defining, Evaluating, and Treating Pre-Aging With a Cosmetic Regimen Containing a Novel Cosmetic Peptide, Acetyl Dipeptide-31 Amide (AP31)

| Featured Articles, The Latest, Video Abstract | No Comments
Featured Video Abstract Check out our all new video abstract from Cheri Frey, MD, where she discusses a scientific approach to defining, evaluating, and treating pre-aging with a cosmetic regimen…

Leave a Reply